UAB "Bioremedium" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
4,000 |
578 |
28,839 |
-28,839 |
-4,167 |
34.54 |
-6.89 |
-673.70 |
-720.98 |
-26,239 |
180,665 |
105,440 |
138,837 |
2022 |
---|
0 |
0 |
102,689 |
-102,689 |
-15,419 |
- |
-1.13 |
- |
- |
-128,927 |
146,225 |
12,446 |
20,179 |
2023 |
---|
0 |
0 |
36,043 |
-36,043 |
-9,611 |
- |
1.74 |
- |
- |
35,029 |
61,118 |
8,179 |
52,166 |
Register and
explore Okredo data2023 |
---|
0 |
0 |
36,043 |
-36,043 |
-9,611 |
- |
1.74 |
- |
- |
35,029 |
61,118 |
8,179 |
52,166 |
Register and
explore Okredo data2023
Turnover (€)
0 €- *
Sales per employee (€)
0 €- *
Profit before tax (€)
36,043 €-65 % *
Net Profit (€)
-36,043 €65 % *
Profit per employee (€)
-9,611 €38 % *
Working capital requirement
-Debt-to-equity ratio
1.74 253.98 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
35,029 €127 % *
Amounts Payable And Liabilities (€)
61,118 €-58 % *
Non-current Assets (€)
8,179 €-34 % *
CurrentAssets (€)
52,166 €159 % *